Top Story

FDA approves clinical trial for potential HCC chemotherapy drug

October 30, 2014

The FDA approved the initiation of an investigational device exemption clinical trial of a potential chemotherapy drug, Oncozene, for the treatment of hepatocellular carcinoma, according to a news release from CeloNova BioSciences.

“Our oncozene microspheres platform, when combined with its precise drug delivery capability, presents a potentially improved treatment option for liver cancer patients,” Jane Ren, PhD, chief technology officer at CeloNova, said in the release.  “We are very pleased to be working with the leading [hepatocellular carcinoma] experts in the world to alleviate the pain of our patients.”

Meeting News Coverage

Over-the-scope clipping system appears viable for endoscopic removal

October 30, 2014
PHILADELPHIA — Endoscopic resection of gastrointestinal tumors with the “over-the-scope clipping system” and cap-assisted technique was shown to be…
figure In the Journals

Thoracic surgeons release new guidelines for treatment of esophageal cancer

October 30, 2014
New evidence-based clinical practice recommendations released by The Society of Thoracic Surgeons outline the importance of multimodality treatment for patients with…
figure In the Journals

'No clear winner' between RYGB, gastric banding

October 29, 2014
Patients who underwent laparoscopic bariatric surgery lost more weight with Roux-en-Y gastric bypass than adjustable gastric banding but had a higher risk for short-term…
More News Headlines »
CME
figure

CRITICAL ISSUES IN HBV: Considerations in Optimizing HBV Treatment

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

Hepatitis B virus (HBV) infection is a global epidemic with a worldwide burden. Physicians must address the importance…
More »
Meeting News Coverage Video
figure

Marshall discusses the safety, efficacy of a potential combination vaccine for infants

October 28, 2014
PHILADELPHIA — At IDWeek 2014, Gary S. Marshall, MD, chief of pediatric infectious diseases at the University of…
More »
CME
figure

Navigating the Roadmap to Remission in Mild to Moderate Ulcerative Colitis

This activity is supported by an educational grant from Santarus

Ulcerative colitis can be a debilitating condition, having a substantial impact on a patient’s quality of life and…
More »